fbpx

ABOUT CONFERENCE

Larix international is delighted to invite you to attend the International Conference on ICCB 2019, one of its remarkable conferences, to be held during June 24th-25th, 2019 in Singapore, emphasizing on recent areas of more optimized research techniques in cancer biology, cancer biomarkers than by traditional hit and trial method. This ICCB 2019 conference includes a wide range of keynote presentations, oral talks, poster presentations, symposia, workshops, exhibitions and career development programs.

Throughout the two day conference, you will have the opportunity to both network and hear leaders from the international academic and corporate pharma companies and cancer communities.

The conference sets the stage for the dissemination and exchange of new developments in diverse, hot fields within cancer biology and anti-cancer therapies, being the platform for inspiration, collaboration and networking for researchers in academia and industry.

Larix International is dedicated nonprofit organization dedicated to building communities that advance the frontiers of science. Our conferences bring a global network of scientists together to discuss the latest pre-publication research in their fields.

Larix Conferences are a group of prestigious international scientific conferences organized by a nonprofit organization of the same name. The conference topics cover frontier research in the medical, life sciences and Engineering and their related technologies.

Why ICCB 2019

The International Congress on Cancer Biology and Anti-Cancer therapies is a unique platform for academic and industrial experts in the world and is the flagship annual event. Your participation in ICCB 2019 will, amongst others, enable you to:

  • Hear plenary lectures by stellar speakers who are leading in cancer and drug discovery developments.
  • Meet Invited speakers who are world leaders in their fields.
  • Present your scientific results to the most relevant audience either as a poster or oral presentations.
  • Get global perspectives in the field of cancer biology and new treatment approaches.
  • Attend Networking events on the first day of the conference.
  • Participate in or visit the Trade Exhibition. Network with oncologists and Pharma from academia and industry from 60+ countries.
  • Become an ICCB 2019 sponsor & Showcase yourself to the world.
  • Present products, services or activities offered by companies & scientific organizations.
  • Attend a publications workshop designed to help young oncologists publish their work in leading cancer journals.

WHY SINGAPORE

  • Singapore is ranked 6th in the WHO of the world’s health systems in 2018.
  • The Economist Intelligence Unit placed Singapore 2nd out of 166 countries for health-care outcomes.
  • Bloomberg Global Health Index ranked Singapore the 4th healthiest country in the world and first in Asia.
  • Singapore healthcare spending has risen from $4 billion in 2011 to $9.8 billion in 2016.
  • Approximately 70–80% of Singaporeans obtain their medical care within the public health system.
  • The World Bank ranked Singapore the second easiest place to do business in the world.
  • Singapore has the second lowest infant mortality in the world and the ninth highest life expectancy.
  • Singapore ranked second-most visited city in Asia-Pacific and fourth-most visited city in the world.